Microbot Medical Inc. (MBOT) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Microbot Medical reported revenue of $0. Net income was -$13.1M, or -$0.29 per diluted share. Operating activities generated -$13.0M of cash, leaving -$13.1M of free cash flow. At fiscal year end, Microbot Medical held $81.5M in total assets against $4.0M in total liabilities, including $3.9M of cash and equivalents.
Open the full interactive Microbot Medical financials → Quarterly statements, key ratios, valuation history and price charts.
Microbot Medical Key Stats
| Share Price | $1.02 |
|---|---|
| Market Cap | $68.5M |
| 52-Week Range | $1.02 – $3.01 |
| Shares Outstanding | 67.2 million (basic, 2026 Q2) |
Microbot Medical Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Goods Sold | — | — | $4.6M | — | — | — |
| Gross Profit | — | — | -$4.6M | — | — | — |
| Operating Income | -$9.1M | -$11.4M | -$13.3M | -$9.9M | -$11.6M | -$14.7M |
| Pre-Tax Income | -$9.2M | -$11.3M | -$13.2M | -$10.7M | -$11.4M | -$13.1M |
| Income Tax | $0 | — | — | — | — | — |
| Net Income | -$9.2M | -$11.3M | -$13.2M | -$10.7M | -$11.4M | -$13.1M |
| Diluted EPS | -$1.29 | -$1.59 | — | -$1.05 | -$0.73 | -$0.29 |
Microbot Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $105,000 | $241,000 |
| Net Income | -$3.6M | -$3.5M | -$3.7M | -$5.6M |
| Diluted EPS | -$0.07 | -$0.08 | -$0.05 | -$0.08 |
Microbot Medical Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $19.6M | $13.5M | $2.4M | $2.5M | $3.1M | $3.9M |
| Current Assets | $25.3M | $15.9M | $8.8M | $7.9M | $5.8M | $79.8M |
| Total Assets | $26.3M | $16.8M | $9.5M | $8.3M | $6.0M | $81.5M |
| Current Liabilities | $1.3M | $2.0M | $2.1M | $3.8M | $2.5M | $3.4M |
| Total Liabilities | $2.0M | $2.4M | $2.2M | $3.8M | $2.5M | $4.0M |
| Shareholders' Equity | $24.3M | $14.4M | $7.3M | $4.5M | $3.5M | $77.6M |
Microbot Medical Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$7.3M | -$9.4M | -$11.5M | -$8.5M | -$8.8M | -$13.0M |
| Cash From Investing | -$2.8M | $3.2M | -$3.8M | $2.0M | $1.5M | -$72.4M |
| Cash From Financing | -$3.4M | — | $4.3M | $6.6M | $7.9M | $86.2M |
| Free Cash Flow | -$7.3M | -$9.4M | -$11.6M | -$8.6M | -$8.9M | -$13.1M |
Figures from Microbot Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Microbot Medical financials page for every line item.
Microbot Medical Company Profile
| Ticker | MBOT |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Hingham, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0000883975 |
Frequently Asked Questions
What was Microbot Medical's revenue in fiscal 2025?
Microbot Medical (MBOT) reported revenue of $0 for fiscal 2025.
What is Microbot Medical's annual revenue history?
Microbot Medical's annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Microbot Medical's net income in fiscal 2025?
Microbot Medical reported net income of -$13.1M for fiscal 2025.
What was Microbot Medical's earnings per share (EPS) in fiscal 2025?
Microbot Medical's diluted EPS was -$0.29 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Microbot Medical generate in fiscal 2025?
Microbot Medical generated -$13.1M of free cash flow in fiscal 2025.
What was Microbot Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), Microbot Medical reported revenue of $241,000.
How many shares of Microbot Medical are outstanding?
Microbot Medical reported a weighted average of 67.2 million basic shares outstanding in 2026 Q2.
What is Microbot Medical's market cap?
Based on its latest closing price, Microbot Medical (MBOT) has a market capitalization of about $68.5M.
When does Microbot Medical's fiscal year end?
Microbot Medical's fiscal year end, as registered with the SEC, is December 31.
Where is Microbot Medical headquartered?
Microbot Medical lists its business address in Hingham, Massachusetts in its SEC filings.